# Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

> **NCT02231931** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Rosuvastatin
- **DRUG:** Digoxin, Furosemide, Metformin hydrochloride, Rosuvastatin
- **DRUG:** Digoxin, Furosemide, Metformin hydrochloride, Rosuvastatin
- **DRUG:** Metformin hydrochloride
- **DRUG:** Digoxin, Furosemide, Metformin hydrochloride, Rosuvastatin
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT02231931
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-01
- **Primary completion:** 2015-01-01
- **Final completion:** 2015-01-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231931, "Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02231931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*